Fingerprint
Dive into the research topics of 'How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
Luis Masana, Nuria Plana, Sofia Pérez-Calahorra, Daiana Ibarretxe, Itziar Lamiquiz-Moneo, Juan Pedro-Botet, Manuel Suárez-Tembra, Pedro Valdivielso, Emilio Ortega, Fernando Civeira
Research output: Contribution to journal › Article › Research › peer-review
15
Citations
(Scopus)